Literature DB >> 11884536

A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.

Hassan M Naif1, Anthony L Cunningham, Mohammed Alali, Shan Li, Najla Nasr, Marc M Buhler, Dominique Schols, Erik de Clercq, Graeme Stewart.   

Abstract

The mechanisms of human immunodeficiency virus (HIV) infection of a man (VH) homozygous for the CCR5Delta32 mutation were investigated, and coreceptors other than CCR5 used by HIV type 1 (HIV-1) isolated from this individual were identified. In contrast to previous reports, this individual's rate of disease progression was not accelerated. Homozygosity for CCR5Delta32 mutation was demonstrated by PCR and DNA sequencing (R. Biti et al., Nat. Med. 3:252-253, 1997). CCR5 surface expression was absent on T lymphocytes and macrophages. HIV was isolated by coculture with peripheral blood mononuclear cells (PBMCs) from siblings who were homozygous (VM) or wild type (WT) for the CCR5Delta32 mutation. The virus demonstrated dual tropism for infection of MT2 cell line and primary macrophages. Sequencing of the full HIV genome directly from the patient's PBMCs revealed 21 nucleotide insertions in the V1 region of gp120. The VH envelope sequence segregated apart from both the T-cell-line-adapted tropic strains NL4-3 and SF2 and M-tropic strain JRFL or YU2 by phylogenetic tree analysis. VH was shown to utilize predominantly CXCR4 for entry into T lymphocytes and macrophages by HOS.CD4 cell infection assay, direct envelope protein fusion, and inhibition by anti-CXCR4 monoclonal antibody (12G5), SDF-1, and AMD3100. Microsatellite mapping demonstrated the separate inheritance of CXCR4 by both homozygote brothers (VH and VM). Our study demonstrates the ability of certain strains of HIV to readily use CXCR4 for infection or entry into macrophages, which is highly relevant to the pathogenesis of late-stage disease and presumably also HIV transmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884536      PMCID: PMC136018          DOI: 10.1128/jvi.76.7.3114-3124.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.

Authors:  C Balotta; P Bagnarelli; M Violin; A L Ridolfo; D Zhou; A Berlusconi; S Corvasce; M Corbellino; M Clementi; M Clerici; M Moroni; M Galli
Journal:  AIDS       Date:  1997-08       Impact factor: 4.177

2.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Authors:  M W Smith; M Dean; M Carrington; C Winkler; G A Huttley; D A Lomb; J J Goedert; T R O'Brien; L P Jacobson; R Kaslow; S Buchbinder; E Vittinghoff; D Vlahov; K Hoots; M W Hilgartner; S J O'Brien
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

3.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

4.  A new SIV co-receptor, STRL33.

Authors:  G Alkhatib; F Liao; E A Berger; J M Farber; K W Peden
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

5.  HIV-1 infection in a man homozygous for CCR5 delta 32.

Authors:  T R O'Brien; C Winkler; M Dean; J A Nelson; M Carrington; N L Michael; G C White
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

6.  Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry.

Authors:  O Pleskoff; C Tréboute; A Brelot; N Heveker; M Seman; M Alizon
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

7.  A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.

Authors:  J F Berson; D Long; B J Doranz; J Rucker; F R Jirik; R W Doms
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry.

Authors:  J D Reeves; A McKnight; S Potempa; G Simmons; P W Gray; C A Power; T Wells; R A Weiss; S J Talbot
Journal:  Virology       Date:  1997-04-28       Impact factor: 3.616

9.  Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection.

Authors:  M Farzan; H Choe; K Martin; L Marcon; W Hofmann; G Karlsson; Y Sun; P Barrett; N Marchand; N Sullivan; N Gerard; C Gerard; J Sodroski
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

10.  CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

Authors:  L Wu; W A Paxton; N Kassam; N Ruffing; J B Rottman; N Sullivan; H Choe; J Sodroski; W Newman; R A Koup; C R Mackay
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  26 in total

1.  Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope.

Authors:  Eric G Meissner; Karen M Duus; Feng Gao; Xiao-Fang Yu; Lishan Su
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

2.  Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.

Authors:  Guity Ghaffari; Daniel L Tuttle; Daniel Briggs; Brant R Burkhardt; Deepa Bhatt; Warren A Andiman; John W Sleasman; Maureen M Goodenow
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

Authors:  Qingwen Jin; Lokesh Agrawal; L Meyer; R Tubiana; Ioannis Theodorou; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1.

Authors:  Prerana Jayakumar; Irina Berger; Frank Autschbach; Mark Weinstein; Benjamin Funke; Eric Verdin; Mark A Goldsmith; Oliver T Keppler
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 5.  Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.

Authors:  Alex D Greenwood; Yasuko Ishida; Sean P O'Brien; Alfred L Roca; Maribeth V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2017-12-13       Impact factor: 11.056

Review 6.  When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?

Authors:  Italo Mocchetti; Lee A Campbell; G Jean Harry; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-15       Impact factor: 4.147

7.  Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.

Authors:  Lachlan Gray; Melissa J Churchill; Niamh Keane; Jasminka Sterjovski; Anne M Ellett; Damian F J Purcell; Pantelis Poumbourios; Chenda Kol; Bin Wang; Nitin K Saksena; Steven L Wesselingh; Patricia Price; Martyn French; Dana Gabuzda; Paul R Gorry
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.

Authors:  Joseph S Anderson; John Javien; Jan A Nolta; Gerhard Bauer
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

9.  Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.

Authors:  Lokesh Agrawal; Xihua Lu; Jin Qingwen; Zainab VanHorn-Ali; Ioan Vlad Nicolescu; David H McDermott; Philip M Murphy; Ghalib Alkhatib
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.

Authors:  Paul R Gorry; Fahim Ahmad; Jon Mohl; Ghalib Alkhatib
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.